Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-26 @ 1:14 AM
Study NCT ID:
NCT00317434
Status:
TERMINATED
Last Update Posted:
2009-12-15
First Post:
2006-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-20
First Submit QC Date:
None
Study First Post Date:
2006-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-12-10
Last Update Post Date:
2009-12-15
Last Update Post Date Type:
ESTIMATED